HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between PTGER4 polymorphisms and inflammatory bowel disease risk in Caucasian: A meta-analysis.

AbstractBACKGROUND:
The results from previous studies on association between prostaglandin E receptor 4 (PTGER4) polymorphisms and inflammatory bowel disease (IBD) risk in Caucasian were conflict. The present study aimed to investigate the genetic association by conducting a meta-analysis.
METHODS:
Systematic literature search was conducted through Wiley Online Library, Chinese National Knowledge Infrastructure (CNKI), and PubMed databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to investigate the associations between rs4613763 T/C, 17234657T/G polymorphisms, and IBD risk in Caucasian.
RESULTS:
Twenty case-control studies consisting of 18,495 Crohn disease (CD) patients and 4203 ulcerative colitis (UC) patients, as well as 26,063 controls were included in this meta-analysis. The rs4613763T/C polymorphism had obvious influence on CD, UC risk in Caucasian. However, rs17234657T/G polymorphism had obvious influence on CD but not UC in Caucasian.
CONCLUSION:
This meta-analysis suggested that both the rs4613763 T/C, rs17234657T/G polymorphisms had obvious influence on risk of CD in Caucasian. In addition, rs4613763 T/C, polymorphism had obvious influence on risk of UC in Caucasian.
AuthorsPeng-Bo Wu, Rao Qian, Chai Hong, Yi-Tian Guo, Yuan-Jie Yu, Guo Zhang, Shi-Yun Tan
JournalMedicine (Medicine (Baltimore)) Vol. 99 Issue 34 Pg. e19756 (Aug 21 2020) ISSN: 1536-5964 [Electronic] United States
PMID32846747 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
Chemical References
  • PTGER4 protein, human
  • Receptors, Prostaglandin E, EP4 Subtype
Topics
  • Genetic Predisposition to Disease
  • Humans
  • Inflammatory Bowel Diseases (genetics)
  • Polymorphism, Single Nucleotide
  • Receptors, Prostaglandin E, EP4 Subtype (genetics)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: